Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Development of a Stability-Indicating RP-HPLC Method for the Determination of Rupatadine and its Degradation Products in Solid Oral Dosage Form.

Trivedi HK, Patel MC.

Sci Pharm. 2012 Dec;80(4):889-902. doi: 10.3797/scipharm.1208-10. Epub 2012 Oct 1.

2.

Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form.

Trivedi RK, Patel MC.

Sci Pharm. 2012 Jun;80(2):353-66. doi: 10.3797/scipharm.1112-08. Epub 2012 Feb 21.

3.
5.

Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.

Krishnaiah Ch, Reddy AR, Kumar R, Mukkanti K.

J Pharm Biomed Anal. 2010 Nov 2;53(3):483-9. doi: 10.1016/j.jpba.2010.05.022.

PMID:
20646890
6.
7.

Development and validation of a stability-indicating RP-LC method for famciclovir.

Raman NV, Harikrishna KA, Prasad AV, Ratnakar Reddy K, Ramakrishna K.

J Pharm Biomed Anal. 2009 Dec 5;50(5):797-802. doi: 10.1016/j.jpba.2009.06.031. Epub 2009 Jun 24.

PMID:
19632799
9.
10.

Development and validation of a simple, sensitive, selective and stability-indicating RP-UPLC method for the quantitative determination of ritonavir and its related compounds.

Koppala S, Panigrahi B, Raju SV, Padmaja Reddy K, Ranga Reddy V, Anireddy JS.

J Chromatogr Sci. 2015 May-Jun;53(5):662-75. doi: 10.1093/chromsci/bmu097. Epub 2014 Sep 3.

11.

A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms.

Rao DD, Satyanarayana NV, Malleswara Reddy A, Sait SS, Chakole D, Mukkanti K.

J Pharm Biomed Anal. 2010 Feb 5;51(3):736-42. doi: 10.1016/j.jpba.2009.09.016. Epub 2009 Sep 20. Erratum in: J Pharm Biomed Anal. 2011 Sep 10;56(2):464.

PMID:
19815361
12.

A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms.

Rao PV, Kumar MN, Kumar MR.

Sci Pharm. 2013 Mar;81(1):183-93. doi: 10.3797/scipharm.1210-09. Epub 2012 Dec 3.

13.

A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.

Lalitha Devi M, Chandrasekhar KB.

J Pharm Biomed Anal. 2009 Dec 5;50(5):710-7. doi: 10.1016/j.jpba.2009.05.038. Epub 2009 Jun 6.

PMID:
19632800
14.
15.

Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form.

Trivedi RK, Patel MC.

Sci Pharm. 2011 Mar;79(1):97-111. doi: 10.3797/scipharm.1009-12. Epub 2011 Jan 16.

16.

Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.

Luo Z, Deng Z, Liu Y, Wang G, Yang W, Hou C, Tang M, Yang R, Zhou H.

Talanta. 2015 Jul 1;139:67-74. doi: 10.1016/j.talanta.2015.02.039. Epub 2015 Feb 27.

PMID:
25882410
17.

Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form.

Venkatarao P, Nagendra Kumar M, Ravi Kumar M.

Sci Pharm. 2012 Dec;80(4):965-76. doi: 10.3797/scipharm.1207-12. Epub 2012 Sep 9.

18.

A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.

Sharma N, Rao SS, Reddy AM.

J Chromatogr Sci. 2012 Oct;50(9):745-55. doi: 10.1093/chromsci/bms025. Epub 2012 May 4.

19.

Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms.

Krishnaiah Ch, Vishnu Murthy M, Kumar R, Mukkanti K.

J Pharm Biomed Anal. 2011 Mar 25;54(4):667-73. doi: 10.1016/j.jpba.2010.10.013. Epub 2010 Oct 28.

PMID:
21075576
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk